CALCULATE YOUR SIP RETURNS

Sheel Biotech IPO Allotment Status

Written by: Aayushi ChaubeyUpdated on: 3 Oct 2025, 10:55 pm IST
Sheel Biotech IPO allotment is expected on Oct 6, 2025. The issue was aimed at raising ₹34.02 crore for capacity expansion and meeting working capital needs.
Sheel Biotech IPO Allotment Status
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Sheel Biotech launched a book-building IPO worth ₹34.02 crore on September 30, 2025. It consisted entirely of a fresh issue of 0.54 crore shares. The IPO has closed today on October 3, 2025.

Allotment of shares is expected to be completed on October 6, and the shares are expected to be listed on NSE SME around October 8. This IPO gave investors an opportunity to participate in Sheel Biotech’s growth.

How to Check Sheel Biotech IPO Allotment Status Online on NSE?

  • Go to the application status page
  • Select "Equity and SME IPO bids"
  • Choose "Sheel Biotech" from the Issue Name dropdown
  • Provide your Application Number or PAN
  • Click on Submit

How to Check Sheel Biotech IPO Allotment Status Online on BSE?

  • Go to the application status page
  • Select "Equity" under the Issue Type
  • Choose "Sheel Biotech" from the Issue Name dropdown
  • Provide your Application Number or PAN
  • Click on “I am not a robot” and submit

How to Check Sheel Biotech IPO Allotment Status Online on the Registrar’s Website?

  • Go to the registrar’s official website.
  • Select "Sheel Biotech" from the company list.
  • Enter your Client ID, Application Number, or PAN.
  • Click on Submit.

Sheel Biotech IPO Details

Sheel Biotech launched a ₹34.02 crore book-building IPO, entirely a fresh issue of 0.54 crore shares. The IPO opened on September 30, 2025, and closed on October 3, 2025, with allotment completed on October 6 and NSE SME listing expected around October 8. The price band was ₹59–₹63 per share, with a lot size of 2,000 shares. Retail minimum was ₹2,52,000, and HNI minimum was ₹3,78,000.

Allocation Quota for Sheel Biotech

The table below breaks down the Sheel Biotech share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.

CategoryShares OfferedSize (%)
Anchor Investor15,24,00022.01%
Market Maker2,72,0003.93%
QIB25,50,00036.83%
NII*7,74,00011.18%
-bNII (bids above ₹10L)5,16,0007.45%
-sNII (bids below ₹10L)2,58,0003.73%
Retail18,04,00026.05%
Total69,24,000100%

Sheel Biotech IPO – Overall Subscription Status

CategorySubscribed
QIB (Ex Anchor)19.73x
NII25.92x
-bNII (>10L)31.64x
-sNII (<10L)14.49x
Individual Investors9.55x
Total15.97x

Note: The subscription details are as of October 3, 2025

Sheel Biotech Business Overview

Sheel Biotech Limited (SBL), founded in 1991 by Dr. Satya Narayan Chandak, is a public company operating in biotechnology, agriculture, and horticulture. It specialises in developing, processing, and supplying plants for crops, fruits, vegetables, and ornamental purposes using tissue culture and organic farming techniques.

SBL runs greenhouses, provides training through Farmer Producer Organizations (FPOs), and offers landscaping services to government and private clients. The company is ISO-certified (9001, 14001, 45001) and its R&D lab, recognized by the Department of Biotechnology, produces 10 million planting materials annually.

Over the years, SBL expanded into protected cultivation and started importing flowers like tulip, lilium, orchids, and alstroemeria. Its organic division promotes sustainable farming, and its operations span India and abroad, including Eritrea. During COVID-19, it produced oxygen-generating plants, reflecting its focus on innovation and accessibility of nutritious fruits.

Know more about IPO allotment status and check your application details online for the latest updates on share allocation.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 
 
 
 
 
 
 
 


 

Published on: Oct 3, 2025, 5:24 PM IST

Aayushi Chaubey

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers